Oxurion NV: OXURION to Participate in Upcoming Investor Meetings
OXURION to Participate in Upcoming Investor Meetings
Leuven, BELGIUM, Boston, MA, US - January 7, 2021 - 08.00 AM CET - Oxurion NV(Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard-of-care ophthalmic therapies, with a focus on diabetic macular edema (DME), today announces its management will participate and meet with investors at the following upcoming virtual meetings: · H.C. Wainwright Bioconnect 2021 Conference
January 11 - 14, 2021 · BIO Partnering at JPM Week
January 11 - 15, 2021
January 11 - 15, 2021 January 4 - 22, 2021 · Degroof Petercam Healthcare Conference
January 26 - 27, 2021
www.oxurion.com/news-eventsview-conferences events-page
Oxurion NV
& Corporate Communications
wouter.piepers@oxurion.com (mailto:wouter.piepers@oxurion.com)